Top compounds associated with response to CDC73


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.007
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.1 0.007
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.088 0.008
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.01
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.081 0.01
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.092 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.088 0.02
Download CSV